Long V Doan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Optical Coherence Tomography

Cataract Surgery

Top Venues

Ophthalmology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jason Bacharach, Long V Doan, Kerry G Stephens, Dale W Usner, Angela C Kothe, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and therapy 13 (9) (2024)
Jason Bacharach, Long V Doan, Kerry G Stephens, Dale W Usner, Angela C Kothe, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and therapy 13 (9) (2024)
Jason Bacharach, Long V Doan, Kerry G Stephens, Dale W Usner, Angela C Kothe, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and therapy (2024)
Steven R Sarkisian, Robert Edward T Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, David Applegate, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial. Ophthalmology and therapy (2024)
Steven R Sarkisian, Robert Edward T Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, David Applegate, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial. Ophthalmology and therapy 13 (4) (2024)
Steven R Sarkisian, Robert Edward T Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, David Applegate, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial. Ophthalmology and therapy 13 (4) (2024)
Jason Bacharach, Long V Doan, Kerry G Stephens, Dale W Usner, Angela C Kothe, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant Demonstrates Superior IOP Lowering Versus Topical Prostaglandin Analog Monotherapy in Patients with Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology and therapy 13 (9) (2024)
Steven R Sarkisian, Robert Edward T Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, David Applegate, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial. Ophthalmology and therapy 13 (4) (2024)
I Paul Singh, John P Berdahl, Steven R Sarkisian, Lilit A Voskanyan, Robert Edward T Ang, Long V Doan, David Applegate, Yannan Shen, L Jay Katz, Angela C Kothe, Tomas Navratil
Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials. Drugs (2024)
Steven R Sarkisian, Robert Edward T Ang, Andy M Lee, John P Berdahl, Sebastian B Heersink, James H Burden, Long V Doan, Kerry G Stephens, David Applegate, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil
Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension: 12-Month Results of a Randomized, Double-Masked Trial. Ophthalmology and therapy 13 (4) (2024)
John P Berdahl, Steven R Sarkisian, Robert Edward T Ang, Long V Doan, Angela C Kothe, Dale W Usner, L Jay Katz, Tomas Navratil, null null
Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension. Drugs (2023)